hyaluronoglucosaminidase has been researched along with nitroglycerin in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (77.78) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (11.11) | 29.6817 |
2010's | 2 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Opolski, G; Zochowski, RJ | 1 |
Belz, GG; Erbel, R | 1 |
Barsamian, E; Braunwald, E; Hillis, LD; Khuri, SF; Kloner, RA; Maroko, PR; Tow, D | 1 |
Zilcher, H | 1 |
Braunwald, E; Hillis, LD | 1 |
Bleifeld, W | 1 |
Kraĭtman, LB | 1 |
Col, JJ | 1 |
Yusuf, S | 1 |
Smith, ER | 1 |
Opie, LH | 1 |
Braunwald, E; Muller, JE; Rude, RE | 1 |
Braunwald, E; Muller, JE | 1 |
Afonskaia, NI; Avaliani, AG; Ruda, MIa; Vikhert, AM; Zysko, AP | 1 |
Cohen, JL; Glaich, AS; Goldberg, LH | 1 |
Cohen, JL; Duffy, D; Hirsch, RJ; Lupo, M | 1 |
Arkins, JP; Dayan, SH; Mathison, CC | 1 |
Biesman, BS; Cohen, JL; Dayan, SH; DeLorenzi, C; Lambros, VS; Nestor, MS; Sadick, N; Sykes, J | 1 |
8 review(s) available for hyaluronoglucosaminidase and nitroglycerin
Article | Year |
---|---|
[Recent aspects on basic drug therapy of acute myocardial infarct].
Topics: Adrenergic beta-Antagonists; Allopurinol; Analgesics; Anticoagulants; Aprotinin; Cardiac Glycosides; Elapid Venoms; Glucocorticoids; Glucose; Humans; Hyaluronoglucosaminidase; Hypnotics and Sedatives; Injections, Intravenous; Insulin; Mannitol; Myocardial Infarction; Nicotinic Acids; Nitrites; Nitroglycerin; Nitroprusside; Potassium; Streptokinase | 1977 |
Myocardial ischemia (third of three parts).
Topics: Acute Disease; Animals; Assisted Circulation; Coronary Disease; Disease Models, Animal; Dogs; Glucocorticoids; Hemodynamics; Humans; Hyaluronoglucosaminidase; Methods; Myocardial Contraction; Myocardial Infarction; Nitroglycerin; Oxygen Inhalation Therapy; Propranolol; Rats; Time Factors | 1977 |
[Possibilities of preserving ischemic myocardium].
Topics: Acute Disease; Animals; Coronary Circulation; Coronary Disease; Dipyridamole; Fibrinolysis; Humans; Hyaluronoglucosaminidase; Myocardial Contraction; Myocardial Infarction; Nitroglycerin; Verapamil | 1976 |
Interventions that potentially limit myocardial infarct size: overview of clinical trials.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Clinical Trials as Topic; Ferricyanides; Fibrinolytic Agents; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Nitroglycerin; Nitroprusside; Random Allocation; Risk; Streptokinase | 1987 |
Acute myocardial infarction and muscle salvage: a potential role for pharmacological agents.
Topics: Adenosine; Adrenergic alpha-Agonists; Animals; Assisted Circulation; Collateral Circulation; Coronary Artery Bypass; Coronary Circulation; Digitalis Glycosides; Diuretics; Electric Stimulation; Glucocorticoids; Glucose; Humans; Hyaluronoglucosaminidase; Insulin; Ischemia; Myocardial Infarction; Myocardium; Necrosis; Nitroglycerin; Oxygen; Oxygen Consumption; Potassium; Propranolol; Ventricular Fibrillation | 1974 |
Myocardial infarct size. Part 2. Comparison of anti-infarct effects of beta-blockade, glucose-insulin-potassium, nitrates, and hyaluronidase.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Glucose; Heart Rate; Heparin; Humans; Hyaluronoglucosaminidase; Hyperglycemia; Insulin; Myocardial Infarction; Nitrates; Nitroglycerin; Nitroprusside; Potassium; Propranolol; Time Factors | 1980 |
Can infarct size be limited in patients with acute myocardial infarction?
Topics: Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Cardiotonic Agents; Coronary Artery Bypass; Coronary Disease; Dogs; Fibrinolytic Agents; Glucose; Humans; Hyaluronoglucosaminidase; Hypertension; Insulin; Intra-Aortic Balloon Pumping; Myocardial Infarction; Necrosis; Nitroglycerin; Oxygen; Oxygen Consumption; Potassium; Vasodilator Agents | 1983 |
Injection necrosis of the glabella: protocol for prevention and treatment after use of dermal fillers.
Topics: Biocompatible Materials; Cardiovascular Agents; Clinical Protocols; Enzyme Therapy; Forehead; Heparin, Low-Molecular-Weight; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intradermal; Necrosis; Nitroglycerin; Subcutaneous Tissue | 2006 |
3 trial(s) available for hyaluronoglucosaminidase and nitroglycerin
Article | Year |
---|---|
Myocardial salvage by medical therapy in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Nitroglycerin; Nitroprusside; Streptokinase | 1985 |
Interventions that potentially limit myocardial infarct size: overview of clinical trials.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Clinical Trials as Topic; Ferricyanides; Fibrinolytic Agents; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Nitroglycerin; Nitroprusside; Random Allocation; Risk; Streptokinase | 1987 |
[Results of trials of limiting the size of the focal lesion in myocardial infarct infarct by drugs].
Topics: Clinical Trials as Topic; Electrocardiography; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Nitroglycerin; Time Factors; Verapamil | 1982 |
8 other study(ies) available for hyaluronoglucosaminidase and nitroglycerin
Article | Year |
---|---|
[Possibilities of reducing of the area of myocardial infarction].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Cardiac Glycosides; Heart Failure; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Nitroglycerin; Shock, Cardiogenic | 1977 |
Assessment of the efficacy of interventions to limit ischemic injury by direct measurement of intramural carbon dioxide tension after coronary artery occlusion in the dog.
Topics: Animals; Arterial Occlusive Diseases; Carbon Dioxide; Coronary Disease; Coronary Vessels; Dogs; Drug Therapy, Combination; Female; Hyaluronoglucosaminidase; Isoproterenol; Male; Myocardium; Nitroglycerin; Propranolol; Regional Blood Flow | 1979 |
[Measures to reduce infarct size (author's transl)].
Topics: Animals; Coronary Artery Bypass; Coronary Circulation; Energy Metabolism; Hemodynamics; Humans; Hyaluronoglucosaminidase; Infusions, Parenteral; Intra-Aortic Balloon Pumping; Methylprednisolone; Myocardial Contraction; Myocardial Infarction; Myocardium; Nitroglycerin; Oxygen Consumption; Shock, Cardiogenic; Vasoconstrictor Agents; Vasodilator Agents | 1979 |
[Value of rheoencephalography in the diagnosis of chronic fibrosing cerebral arachnoiditis and several questions concerning therapy].
Topics: Adolescent; Adult; Arachnoiditis; Cell- and Tissue-Based Therapy; Cerebrovascular Circulation; Chronic Disease; Desensitization, Immunologic; Female; Humans; Hyaluronoglucosaminidase; Male; Nitroglycerin; Plethysmography, Impedance; Vitreous Body | 1976 |
Efforts to limit the size of myocardial infarcts.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Creatine Kinase; Electrocardiography; Fibrinolytic Agents; Glucose; Humans; Hyaluronoglucosaminidase; Insulin; Intra-Aortic Balloon Pumping; Isoenzymes; Myocardial Infarction; Nitroglycerin; Oxygen; Perfusion; Potassium; Vasodilator Agents | 1981 |
Delayed presentation of impending necrosis following soft tissue augmentation with hyaluronic acid and successful management with hyaluronidase.
Topics: Administration, Topical; Adult; Cosmetic Techniques; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intravenous; Necrosis; Nitroglycerin; Skin Aging; Vasodilator Agents | 2007 |
Management of impending necrosis associated with soft tissue filler injections.
Topics: Adult; Antacids; Aspirin; Cosmetic Techniques; Durapatite; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections; Necrosis; Nitroglycerin; Oxygen | 2011 |
Treatment of Hyaluronic Acid Filler-Induced Impending Necrosis With Hyaluronidase: Consensus Recommendations.
Topics: Aspirin; Dermal Fillers; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Massage; Necrosis; Nitroglycerin; Platelet Aggregation Inhibitors; Vasodilator Agents; Viscosupplements | 2015 |